News

The FDA has approved Anzupgo (delgocitinib) cream for the topical treatment of moderate to severe chronic hand eczema in ...
With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of these therapies.
Benefits of 7000 steps per day include lower risk for death and cardiovascular disease, diabetes, dementia, and depression.
RFK Jr may remove all 16 members of the advisory group that helps decide which preventive services are fully covered by insurance.
Nearly half of all Planned Parenthood patients use Medicaid to pay for services. Medicaid is the federal health care program for people with low incomes or disabilities. In her ruling, Talwani ...
Tildrakizumab is an interleukin-23 antagonist approved under the brand name Ilumya for the treatment of plaque psoriasis.
The FDA is recommending that certain products containing 7-hydroxymitragynine be subject to the Controlled Substances Act.